Spots Global Cancer Trial Database for endometrial clear cell carcinoma
Every month we try and update this database with for endometrial clear cell carcinoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Whole-Abdominal Radiation Therapy and Cisplatin in Treating Patients With Stage III or Stage IV Endometrial Cancer That Has Been Removed by Surgery | NCT00448643 | Endometrial Can... | Vaginal Brachyt... Cisplatin Whole Abdominal... | 18 Years - 80 Years | University of Miami | |
Randomized Trial of Radiation Therapy With or Without Chemotherapy for Endometrial Cancer | NCT00411138 | Endometrial Can... | Radiation Thera... cisplatin carboplatin Paclitaxel | 18 Years - 90 Years | Leiden University Medical Center | |
Radiation or Observation Only in Endometrial Cancer Who Have Undergone Surgery | NCT00002807 | Endometrial Can... | radiation thera... | - 120 Years | Canadian Cancer Trials Group | |
Surgery With or Without Lymphadenectomy and Radiation Therapy in Treating Patients With Endometrial Cancer | NCT00003749 | Endometrial Can... | adjuvant therap... conventional su... brachytherapy radiation thera... | - | National Cancer Institute (NCI) | |
Ridaforolimus in Treating Patients With Recurrent Metastatic and/or Locally Advanced Endometrial Cancer | NCT00770185 | Endometrial Can... | ridaforolimus gene expression... immunohistochem... laboratory biom... | 18 Years - | Canadian Cancer Trials Group | |
Comparison of Radiation Therapy With or Without Combination Chemotherapy Following Surgery in Treating Patients With Stage I or Stage II Endometrial Cancer | NCT00006027 | Endometrial Can... | cisplatin paclitaxel adjuvant therap... radiation thera... | 18 Years - 120 Years | Radiation Therapy Oncology Group | |
S9720 Combination Chemotherapy in Treating Patients With Metastatic, Recurrent, or Refractory Endometrial Cancer | NCT00003127 | Endometrial Can... | amifostine trih... carboplatin paclitaxel | 16 Years - | SWOG Cancer Research Network | |
Whole-Abdominal Radiation Therapy and Cisplatin in Treating Patients With Stage III or Stage IV Endometrial Cancer That Has Been Removed by Surgery | NCT00448643 | Endometrial Can... | Vaginal Brachyt... Cisplatin Whole Abdominal... | 18 Years - 80 Years | University of Miami | |
Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Advanced Endometrial Cancer | NCT00002493 | Endometrial Can... Psychosocial Ef... | cisplatin doxorubicin hyd... low-LET photon ... | - | GOG Foundation | |
Radiation Therapy With or Without Chemotherapy in Treating Patients With High-Risk Endometrial Cancer | NCT00005583 | Endometrial Can... | cisplatin doxorubicin hyd... epirubicin hydr... adjuvant therap... conventional su... radiation thera... | - | National Cancer Institute (NCI) | |
Thalidomide in Treating Patients With Recurrent or Persistent Endometrial Cancer | NCT00025467 | Endometrial Ade... Endometrial Ade... Endometrial Ade... Endometrial Cle... Endometrial Pap... Recurrent Endom... | thalidomide laboratory biom... | - | National Cancer Institute (NCI) | |
Temsirolimus in Treating Patients With Metastatic or Locally Advanced Recurrent Endometrial Cancer | NCT00072176 | Endometrial Ade... Endometrial Ade... Endometrial Cle... Endometrial Pap... Recurrent Endom... Stage IIIA Endo... Stage IIIB Endo... Stage IIIC Endo... Stage IVA Endom... Stage IVB Endom... | temsirolimus laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
Surgery With or Without Lymphadenectomy and Radiation Therapy in Treating Patients With Endometrial Cancer | NCT00003749 | Endometrial Can... | adjuvant therap... conventional su... brachytherapy radiation thera... | - | National Cancer Institute (NCI) | |
Study Of Nintedanib Compared To Chemotherapy in Patients With Recurrent Clear Cell Carcinoma Of The Ovary Or Endometrium | NCT02866370 | Ovarian Clear C... Endometrial Cle... | Nintedanib Paclitaxel Pegylated Lipos... Topotecan Carboplatin Doxorubicin | 18 Years - | NHS Greater Glasgow and Clyde | |
Role of Biomarkers in Endometrial Cancer Recurrence in Samples From Patients With Stage II, Stage III, or Stage IV Endometrial Cancer | NCT01150682 | Endometrial Can... | RNA analysis reverse transcr... enzyme-linked i... immunohistochem... laboratory biom... | - | National Cancer Institute (NCI) | |
Thalidomide in Treating Patients With Recurrent or Persistent Endometrial Cancer | NCT00025467 | Endometrial Ade... Endometrial Ade... Endometrial Ade... Endometrial Cle... Endometrial Pap... Recurrent Endom... | thalidomide laboratory biom... | - | National Cancer Institute (NCI) | |
Liposome-Encapsulated Doxorubicin Citrate and Carboplatin in Treating Patients With Advanced or Metastatic Recurrent Endometrial Cancer | NCT01100359 | Endometrial Can... | carboplatin liposome-encaps... laboratory biom... quality-of-life... | 18 Years - | National Cancer Institute (NCI) | |
Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Advanced Endometrial Cancer | NCT00002493 | Endometrial Can... Psychosocial Ef... | cisplatin doxorubicin hyd... low-LET photon ... | - | GOG Foundation | |
Study Of Nintedanib Compared To Chemotherapy in Patients With Recurrent Clear Cell Carcinoma Of The Ovary Or Endometrium | NCT02866370 | Ovarian Clear C... Endometrial Cle... | Nintedanib Paclitaxel Pegylated Lipos... Topotecan Carboplatin Doxorubicin | 18 Years - | NHS Greater Glasgow and Clyde | |
Randomized Trial of Radiation Therapy With or Without Chemotherapy for Endometrial Cancer | NCT00411138 | Endometrial Can... | Radiation Thera... cisplatin carboplatin Paclitaxel | 18 Years - 90 Years | Leiden University Medical Center |